Иммунологические свойства мультипотентных мезенхимальных стромальных клеток
- Авторы: Сергеев В.С.
- Выпуск: № 2 (2005)
- Страницы: 39-42
- Раздел: Мини-обзоры
- Статья получена: 04.03.2023
- Статья одобрена: 04.03.2023
- Статья опубликована: 06.03.2023
- URL: https://genescells.ru/2313-1829/article/view/313380
- ID: 313380
Цитировать
Полный текст
![Открытый доступ](https://genescells.ru/lib/pkp/templates/images/icons/text_open.png)
![Доступ закрыт](https://genescells.ru/lib/pkp/templates/images/icons/text_unlock.png)
![Доступ закрыт](https://genescells.ru/lib/pkp/templates/images/icons/text_lock.png)
Полный текст
![Доступ закрыт](https://genescells.ru/lib/pkp/templates/images/icons/text_lock.png)
Список литературы
- Dejbakhsh-Jones S., Jerabek L., Weissman I.L., Strober S. Extrathymic maturation of alpha beta T cells from hemopoietic stem cells. J. Immunol. 1995; 155: 3338-44.
- Barda-Saad M., Rozenszajn L.A., Globerson A. et al. Selective adhesion of immature thymocytes to bone marrow stromal cells: relevance to T cell lymphopoiesis. Exp. Hematol. 1996; 24: 386-91.
- Le Blanc K., Tammik C., Rosendahl K. et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. 2003; 31: 890-6.
- Krampera M., Glennie S., Dyson J. et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722-9.
- Rasmusson I., Ringden O., Sundberg B. et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003; 76: 1208-13.
- Tse W., Pendleton J., Beyer W. et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003; 75: 389-97.
- Bartholomew A., Sturgeon C., Siatskas M. et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 2002; 30: 42-8.
- Di Nicola M., Carlo-Stella C., Magni M. et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-43.
- Meisel R., Zibert A., Laryea M. et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004; 103: 4619-21.
- Djouad F., Plence P., Bony C. et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003; 102: 3837-44.
- Le Blanc K., Rasmusson I., Gotherstrom C. et al. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand. J. Immunol. 2004; 60: 307-15.
- Aggarwal S., Pittenger M. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-22.
- Jiang X.X., Zhang Y., Liu B. et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood. 2005; 105(10):4120-6.
- Grinnemo K.H., Mansson A., Dellgren G. et al. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J. Thorac. Cardiovasc. Surg. 2004; 127: 1293-300.
- Silverstein A., Prendergast R., Kraner K. Fetal response to antigenic stimulus IV. Rejection of skin homografts by the fetal lamb. J. Exp. Med. 1964; 119: 955-64.
- Liechty K., MacKenzie T., Shaaban A. et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat. Med. 2000; 11: 1282-6.
- Saito T., Kuang J.Q., Bittira B. et al. Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann. Thorac. Surg. 2002; 74: 19-24.
- Majumdar M.K., Keane-Moore M., Buyaner D. et al. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J. Biomed. Sci. 2003; 10: 228-41.
- Munn D.H., Shafizadeh E., Attwood J.T. et al. Inhibition of T-cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 1999; 189: 1363-72.
- Hwu P., Du M.X., Lapointe R. et al. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J. Immunol. 2000; 164: 3596-9.
- Schwartz R.H. A cell culture model for T lymphocyte clonal anergy. Science 1990; 248: 1349-56.
- Frassoni F., Podesta M., Piaggio G. et al. Expanded mesenchymal stem cells (MSC), co-infused with HLA identical hematopoietic stem cell transplants, reduce acute and chronic graft-versus-host disease: a matched pair analysis. Bone Marrow Transplant. 2002; 29 (suppl 2): S2 abstract.
- Koc O., Gerson S., Cooper B. et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J. Clin. Oncol. 2000; 18: 307-16.
- Horwitz E.M., Prockop D.J., Fitzpatrick L.A. et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 1999; 5: 309-13.
- Le Blanc K., Rasmusson I., Sundberg B. et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-41.
- Chung N.G., Jeong D.C., Park S.J. et al. Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation. Int. J. Hematol. 2004; 80; 4: 370-6.
- Maitra B., Szekely E., Gjini K. et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 2004; 33; 6: 597-604.
- Lazarus H.M., Koc O.N., Devine S.M. et al. Cotransplantation of HLA- identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol. Blood. Marrow. Transplant. 2005; 11; 5: 389-98.
- Arinzeh T.L., Peter S.J., Archambault M.P. et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J. Bone Joint Surg. Am. 2003; 85-A; 10: 1927-35.
- Niemeyer P., Seckinger A., Simank H.G. et al. Allogenic transplantation of human mesenchymal stem cells for tissue engineering purposes: an in vitro study. Orthopade (Germany) 2004; 33; 12: 1346-53.
- Nevo Z., Robinson D., Horowitz S. et al. The manipulated mesenchymal stem cells in regenerated skeletal tissues. Cell Transplant. 1998; 7; 1: 63-70.
- http://www.osiristx.com/index_files/Patents.htm
- Jorgensen C., Djouad F., Apparailly F., Noel D. Engineering mesenchymal stem cells for immunotherapy. Gene Therapy 2003; 10: 928-31.
Дополнительные файлы
Доп. файлы
Действие
1.
JATS XML
Скачать (155KB)
3.
Рис. 2. Возможные механизмы иммунологических эффектов, опосредованных ММСК [MSC/SSC]:Активация Т-клеточного рецептора лимфоцитов реципиента [TCR-CD3] без сопутствующей CD28- костимуляциии.Взаимодействие неизвестных поверхностных молекул.Секреция ММСК простагландина E2 [PGE2].Индукция экспрессии в ММСК фермента indoleamine 2,3-dioxygenase [IDO], который катализирует конверсию триптофана в кинуреин.Секреция ММСК трансформирующего фактора роста бета [TGF ß] и фактора роста гепатоцитов [HGF].Секреция ММСК неизвестного растворимого посредника, с выраженной иммуносупрессивной активностью
Скачать (229KB)
![](/img/style/loading.gif)